Molecular epidemiology of gastric cancer

Digestive Diseases

Volumn 25, Issue 3, 2007, Pages 222-224

  Starzyńska, Teresa ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Gastric cancer; Markers of exposure; Markers of susceptibility; Molecular epidemiology

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; DISEASE MARKER; EPSTEIN BARR VIRUS; FAMILIAL CANCER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; JC VIRUS; MOLECULAR EPIDEMIOLOGY; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER; STOMACH MUCOSA; VIRUS CARCINOGENESIS; VIRUS ETIOLOGY; ARTICLE; CARCINOMA; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; MICROBIOLOGY; STOMACH TUMOR; VIRUS INFECTION;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; CARCINOMA; EPIDEMIOLOGY, MOLECULAR; EPSTEIN-BARR VIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERPESVIRUS 4, HUMAN; HUMANS; JC VIRUS; POLYOMAVIRUS INFECTIONS; STOMACH NEOPLASMS;

EID: 35448954472     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103889     Document Type: Conference Paper

References (12)

1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Chen Y-C, Hunter DJ: Molecular epidemiology of cancer. CA Cancer J Clin 2005;55:45-54.
3. Suganuma M, Kuzuhara T, Yamaguchi K, Fujiki H: Cancerogenic role of tumour necrosis factor-α inducing protein of Helicobacter pylori in human stomach. J Biochem Mol Biol 2006;39:1-8.
4. Houghton J, Stoicov C, Roger A, Carbon J, Li H, Cai X, Fox J, Goldering J, Wang T: Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568-1571.
5. Stadtlander CH, Waterbor JW: Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 1999;20:2195-2208.
6. Corvalan A, Ding S, Koriyama C, Carrascal E, Carrasquilla G, Backhouse C, Urza L, Argadona J, Palma M, Eizuru Y, Akiba S: Association of a distinctive statin of Epstein-Barr virus with gastric cancer. Int J Cancer 2006;118:1736-1742.
7. Ojima H, Saito K, Yamauchi H, Yamaki E, Idetu A, Hosouchi Y, Nishida Y, Tukada K, Kato H, Kuwano H: p16 protein abnormality in Epstein-Barr virus-associated gastric carcinoma. Anticancer Res 2006;26:933-937.
8. Shin SK, Li MS, Fuerst F, Hotchkiss E, Meyer R, Kim IT, Goel A, Boland CR: Oncogenic T-antigen of JC virus is present frequently in human gastric cancer. Cancer 2006;107:481-488.
9. El-Omar EM, Carrington M, Chow WH, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402. Erratum in Nature 2001;412:99.
10. Starzynska T, Malfertheiner P: Helicobacter and digestive malignancies. Helicobacter 2006;11:32-35.
11. Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, Hishida A, Ishizaki T: Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Aliment Pharmacol Ther 2005;22:1033-1040.
12. Jakubowska A, Scott R, Menkiszak J, Gronwald J, Byrski T, Huzarski T, Górskii B, Cybulski C, Dȩbniak T, Kowalska E, Starzyńska T, Ławniczak M, Narod S, Lubiński J: A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer. Eur J Hum Genet 2003;12:955-958.